NASDAQ:SPRO | News — Page 2 | Spero Therapeutics, Inc.

SPRO News — Page 2

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2019-01-07Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 1.01,8.01,9.01.
2018-11-16Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 1.01,3.02,3.03,5.03,9.01.
2018-11-13Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01.
2018-11-08Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2018-09-27Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2018-08-14Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01.
2018-08-09Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2018-07-17Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 5.03,9.01.
2018-07-16Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2018-07-09Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2018-07-09Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 2.02,8.01,9.01.
2018-06-08Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 5.07.
2018-05-10Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2018-04-02Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2018-02-01Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01.
2018-01-23Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 1.01,2.03,9.01.
2017-12-14Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2017-11-06Current reportSEC filingSpero Therapeutics, Inc. filed Form 8-KSpero Therapeutics, Inc. filed Form 8-K covering items 5.02,5.03,8.01,9.01.